ANTIBODY IMMUNITY TO PROSTATE CANCER ASSOCIATED ANTIGENS CAN BE DETECTED IN THE SERUM OF PATIENTS WITH PROSTATE CANCER
- 1 November 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 164 (5), 1825-1829
- https://doi.org/10.1016/s0022-5347(05)67114-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- p53 autoantibodies in patients with urological tumoursBritish Journal of Urology, 1998
- In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific AntigenJNCI Journal of the National Cancer Institute, 1997
- Circulating antibodies against p53 protein in patients with ovarian carcinomaCancer, 1996
- Loss of HLA class I expression in prostate cancer: Implications for immunotherapyUrology, 1995
- Serum p53 antibodies as early markers of lung cancerNature Medicine, 1995
- Serum p53 auto-antibodies: Incidence in familial breast cancerEuropean Journal Of Cancer, 1994
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.Proceedings of the National Academy of Sciences, 1994
- CIRCULATING ANTIBODY TO PROSTATE ANTIGEN IN PATIENTS WITH PROSTATIC CANCERAnnals of the New York Academy of Sciences, 1983
- The immune response to prostate cancer: An evaluation and a reviewJournal of Surgical Oncology, 1980
- Immunosuppression of cell- and serum- mediated tumour-associated immunity in prostatic cancer by human seminal plasmaEuropean Journal of Cancer (1965), 1980